NanoBio® is a biopharmaceutical company focused on developing and commercializing topical and mucosal antimicrobial products derived from its patented NanoStat™ technology platform.
The researcher/inventor is James R. Baker, Jr. MD, the CSO of NanoBio® Corporation. At the University of Michigan, Dr. Baker is the Ruth Dow Doan Professor at the School of Medicine; Chief, Division of Allergy; and Director of the University of Michigan Nanotechnology Institute for Medicine and Biomedical Studies (M-NIMBS).
NanoBio's commercial product pipeline consists of six promising pharmaceuticals. The company's two lead products are treatments for cold sores (herpes labialis) and nail fungus (onychomycosis). Treatments for MRSA, genital herpes, and shingles, are in varying stages of development.
In addition, a vaccine prototype based on the NanoStat platform not requiring refrigeration or the use of needles is being developed for NanoBio by M-NIMBS. This effort is funded by a $6.3 million grant. NanoBio owns rights to all intellectual property related to the product and will direct development after the clinical proof-of-concept is completed by M-NIMBS. The technology also has the potential for facilitating a wide range of additional products including nasal spray vaccines.
NanoBio to Present New Safety Data of Nanoemulsion Adjuvanted Intramuscular Vaccine for RSV Prevention
NanoBio to Develop RSV Intranasal Vaccine with $6 Million Grant
NanoBio Presents Positive Study Results of Intranasal Vaccine at GCGH Meeting
Seventh U.S. Patent for Nanoemulsion Technology Awarded to NanoBio
NanoBio Awarded Patent Covering its Novel Nanoemulsion Technology
Nanoemulsion-based Vaccine to Combat a Wide Variety of Antigens
NanoBio to Present Studies at ICAAC 2009
NanoBio to Present Preclinical Data at Immunotherapeutics and Vaccine Summit
NanoBio to Present Data on Nanoemulsions for Treatment of Acne
Funds Will Support Clinical Trials and Ongoing Operations Through Early 2011
Ping Wang, Ph.D.
We speak with researchers behind the latest advancement in graphene hBN research that could boost the development of next-generation electronic and quantum devices.
Dr. Laurene Tetard
AZoNano speaks with Dr. Laurene Tetard from the University of Central Florida about her upcoming research into the development of nanotechnology that can detect animal-borne diseases. The hope is that such technology can be used to help rapidly control infected mosquito populations to protect public
Dr. Amir Sheikhi
AZoNano speaks with Dr. Amir Sheikhi from Pennsylvania State University about his research into creating a new group of nanomaterials designed to capture chemotherapy drugs before they impact healthy tissue, amending a fault traditionally associated with conventional nanoparticles.
The Filmetrics F40 turns your benchtop microscope into an instrument for measuring thickness and refractive index.
Nikalyte’s NL-UHV is a state-of-the-art tool that allows the generation and deposition of nanoparticles in an Ultra-High vacuum onto a sample to create a functionalized surface.
The Filmetrics® F54-XY-200 is a thickness measurement tool created for automated sequence measurement. It is available in various wavelength configuration options, allowing compatibility with a range of film thickness measurement applications.